Eudaimonia Asset Management »

Immunovant shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 103k 38.37
2023-06-30 $755k 40k 18.97
2020-12-31 $1.5M 33k 46.19
2020-09-30 $1.2M 35k 35.18

More positions owned by Eudaimonia Asset Management

Powell Industries Common Stock (POWL)
Cymabay Therapeutics Common Stock
Aehr Test Systems Common Stock (AEHR)
MiMedx Group Common Stock (MDXG)
Hudson Technologies Common Stock (HDSN)
RxSight Common Stock (RXST)
Applied Optoelectronics Common Stock (AAOI)
Vivo Capital Common Stock (SLNO)
Gambling.com Group Common Stock (GAMB)
Limbach Holdings Common Stock (LMB)
Roivant Sciences Common Stock (IMVT)
Arlo Technologies Common Stock (ARLO)
PetIQ Common Stock (PETQ)
Newpark Resources Common Stock (NR)
Avita Medical Common Stock (RCEL)

View all positions for Eudaimonia Asset Management

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant